Bolt Biotherapeutics, Inc. (BOLT) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer. The company's pipeline products include BDC-4182, a next-generation Boltbody ISAC that targets the tumor-associated antigen claudin 18.2 for the treatment of…
Source: Yahoo Finance
Sector & Industry
Bolt Biotherapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Bolt Biotherapeutics, Inc. at a Glance
| Company | Bolt Biotherapeutics, Inc. |
| Ticker | BOLT |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $3.90 |
| Market cap | $7.51M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$16.51 |
| 52-week high | $7.20 |
| 52-week low | $3.13 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.09 |
| Return on equity (ROE) | -111.65% |
| Debt-to-equity | 171.08% |
| Average volume | 24,080 |
| Shares outstanding | 1.93M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 23 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Bolt Biotherapeutics, Inc.'s current P/E ratio?
- Bolt Biotherapeutics, Inc. (BOLT) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Bolt Biotherapeutics, Inc.'s market capitalisation?
- Bolt Biotherapeutics, Inc.'s market cap is $7.51M based on our latest snapshot. See how it ranks by market cap →
- What is BOLT's 52-week range?
- Over the past 52 weeks, BOLT has traded between $3.13 and $7.20. What does the 52-week range mean? →
- How volatile is Bolt Biotherapeutics, Inc. compared to the market?
- Bolt Biotherapeutics, Inc. has a beta of 1.09, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Bolt Biotherapeutics, Inc. pay a dividend?
- Bolt Biotherapeutics, Inc. does not currently pay a dividend according to our latest data.
- What exchange is BOLT listed on?
- BOLT is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Bolt Biotherapeutics, Inc. in?
- Bolt Biotherapeutics, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →